Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-06-05
2007-06-05
Kam, Chih-Min (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S009100, C530S317000, C530S321000, C530S335000, C530S336000, C530S337000
Reexamination Certificate
active
09742008
ABSTRACT:
The invention concerns a novel method for preparing an intermediate polyanion for preparing cyclosporin derivatives by treating a cyclosporin with a hexamethyldisilazane metal salt, optionally in the presence of a metal halide. The treated cyclosporin has one or several free hydroxy groups and/or non-methylated nitrogen atoms in position α and/or any other acid group capable of deprotonation which are optionally deprotonated or in protected form.
REFERENCES:
patent: 4703033 (1987-10-01), Seebach
patent: 4771122 (1988-09-01), Seebach
patent: 4937355 (1990-06-01), Kloss et al.
patent: 5559256 (1996-09-01), Gordon et al.
patent: 5767069 (1998-06-01), Ko et al.
patent: 5994299 (1999-11-01), Barriere et al.
patent: 0 194 972 (1986-09-01), None
patent: 0 357 428 (1990-03-01), None
patent: 0 379 063 (1990-07-01), None
patent: 0 484 281 (1992-05-01), None
Seebach et al. , Helvetica Chimica Acta 76, 1564-1590 (1993).
Seebach et al., “Modification of Cyclosporin A (CS): Generation of an Enolate at the Sarcosine Residue and Reactions with Electrophiles,”Helvetica Chimica Acta, 76:1564-90 (1993).
T.L. Rathman, “Lithium reagents for syntheses: lithium diisopropylamide and lithium hexamethyldisilazide,”Spec. Chem., 9:300-306 (1989).
S.L. Belagali et al., “A highly efficient method of N-methylation for the amino acid derivatives,”Indian J. Chem., 34B:45-47 (1995).
K.S. Chu et al., “Asymmetric Total Synthesis of (+)-Jasplakinolide,”J. Org. Chem., 56:5196-5202 (1991).
Aventis Pharma S.A.
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Kam Chih-Min
LandOfFree
Process for the preparation of cyclosporin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for the preparation of cyclosporin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the preparation of cyclosporin derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3869054